• 1. Etching of glass microchips with supercritical water?
  Pavel Karásek,Jakub Grym,Michal Roth,Josef Planeta,Franti?ek Foret Lab Chip, 2015,15, 311-318
• 2. Fatty acid positional distribution in colostrum and mature milk of women living in Inner Mongolia, North Jiangsu and Guangxi of China?
  Long Deng,Qian Zou,Biao Liu,Wenhui Ye,Chengfei Zhuo,Li Chen,Ze-Yuan Deng,Ya-Wei Fan,Jing Li Food Funct., 2018,9, 4234-4245
• 3. Emulsion technologies for multicellular tumour spheroid radiation assays?
  Kay S. McMillan,Anthony G. McCluskey,Annette Sorensen,Marie Boyd,Michele Zagnoni Analyst, 2016,141, 100-110
• 4. Dissociative electron attachment to HGaF4 Lewis–Br?nsted superacid
  Marcin Czapla,Jack Simons Phys. Chem. Chem. Phys., 2018,20, 21739-21745
• 5. Excited-state proton-coupled electron transfer within ion pairs?
  Gerald J. Meyer,Leif Hammarstr?m Chem. Sci., 2020,11, 3460-3473

Recent Advances in the Study of (2-fluoro-5-nitrophenyl)methanesulfonamide (CAS: 841476-36-6): A Comprehensive Research Brief

The compound (2-fluoro-5-nitrophenyl)methanesulfonamide (CAS: 841476-36-6) has recently garnered significant attention in the field of chemical biology and pharmaceutical research due to its potential applications in drug discovery and development. This research brief aims to synthesize the latest findings related to this compound, focusing on its synthesis, biological activity, and therapeutic potential. The following sections provide a detailed overview of the current state of research, highlighting key methodologies, results, and implications for future studies.

Recent studies have explored the synthetic pathways for (2-fluoro-5-nitrophenyl)methanesulfonamide, emphasizing its role as a versatile intermediate in the preparation of more complex pharmacologically active molecules. Researchers have employed advanced techniques such as NMR spectroscopy and mass spectrometry to characterize the compound, ensuring high purity and structural integrity. These efforts have facilitated its use in subsequent biological assays, where it has demonstrated promising activity against specific molecular targets.

In vitro and in vivo studies have revealed that (2-fluoro-5-nitrophenyl)methanesulfonamide exhibits notable inhibitory effects on certain enzymes involved in inflammatory and oncogenic pathways. For instance, one study reported its efficacy in suppressing the activity of cyclooxygenase-2 (COX-2), a key enzyme in the inflammatory response. Another investigation highlighted its potential as a modulator of protein kinases, suggesting its applicability in cancer therapy. These findings underscore the compound's multifaceted biological profile and its relevance to multiple therapeutic areas.

Despite these promising results, challenges remain in optimizing the pharmacokinetic and pharmacodynamic properties of (2-fluoro-5-nitrophenyl)methanesulfonamide. Researchers are currently investigating structural modifications to enhance its bioavailability and reduce off-target effects. Computational modeling and high-throughput screening are being utilized to identify derivatives with improved efficacy and safety profiles. These efforts are expected to pave the way for preclinical and clinical evaluations in the near future.

In conclusion, (2-fluoro-5-nitrophenyl)methanesulfonamide (CAS: 841476-36-6) represents a compelling area of research within the chemical biology and pharmaceutical sectors. Its diverse biological activities and potential therapeutic applications make it a valuable candidate for further investigation. Continued exploration of its mechanisms of action and optimization of its chemical properties will be critical in unlocking its full potential. This research brief serves as a foundation for future studies, providing a comprehensive overview of the current knowledge and highlighting avenues for further exploration.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)